Kevin P. Hill

1.8k total citations · 1 hit paper
31 papers, 1.2k citations indexed

About

Kevin P. Hill is a scholar working on Pharmacology, Epidemiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kevin P. Hill has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 8 papers in Epidemiology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kevin P. Hill's work include Cannabis and Cannabinoid Research (11 papers), Substance Abuse Treatment and Outcomes (7 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Kevin P. Hill is often cited by papers focused on Cannabis and Cannabinoid Research (11 papers), Substance Abuse Treatment and Outcomes (7 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Kevin P. Hill collaborates with scholars based in United States, Canada and Jordan. Kevin P. Hill's co-authors include Brian Johnson, Joseph W. Ditre, Roger D. Weiss, Garrett M. Fitzmaurice, Margaret L. Griffin, Kathleen M. Carroll, David Egilman, Harlan M. Krumholz, James Poling and Joseph S. Ross and has published in prestigious journals such as JAMA, Annals of Internal Medicine and NeuroImage.

In The Last Decade

Kevin P. Hill

29 papers receiving 1.2k citations

Hit Papers

Medical Marijuana for Treatment of Chronic Pain and Other... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin P. Hill United States 15 700 247 239 186 180 31 1.2k
Michelle Sexton United States 18 911 1.3× 162 0.7× 213 0.9× 79 0.4× 155 0.9× 26 1.2k
Shanna Babalonis United States 17 728 1.0× 284 1.1× 125 0.5× 167 0.9× 104 0.6× 37 1.1k
Pamela Sabioni Canada 13 663 0.9× 153 0.6× 345 1.4× 106 0.6× 158 0.9× 19 968
Erik W. Gunderson United States 19 679 1.0× 458 1.9× 338 1.4× 237 1.3× 328 1.8× 31 1.5k
Daniel K. Hall‐Flavin United States 24 351 0.5× 188 0.8× 243 1.0× 145 0.8× 250 1.4× 47 1.7k
José Pérez de los Cobos Spain 19 422 0.6× 334 1.4× 605 2.5× 371 2.0× 275 1.5× 64 1.6k
Nicolas J. Schlienz United States 17 594 0.8× 170 0.7× 192 0.8× 53 0.3× 124 0.7× 34 873
Rudolf Stohler Switzerland 17 274 0.4× 213 0.9× 365 1.5× 311 1.7× 93 0.5× 57 1.1k
Eva Hoch Germany 20 867 1.2× 135 0.5× 426 1.8× 79 0.4× 347 1.9× 87 1.4k
Amine Benyamina France 17 287 0.4× 153 0.6× 204 0.9× 118 0.6× 322 1.8× 48 964

Countries citing papers authored by Kevin P. Hill

Since Specialization
Citations

This map shows the geographic impact of Kevin P. Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin P. Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin P. Hill more than expected).

Fields of papers citing papers by Kevin P. Hill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin P. Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin P. Hill. The network helps show where Kevin P. Hill may publish in the future.

Co-authorship network of co-authors of Kevin P. Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin P. Hill. A scholar is included among the top collaborators of Kevin P. Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin P. Hill. Kevin P. Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Michael, et al.. (2025). Therapeutic Use of Cannabis and Cannabinoids. JAMA. 335(4). 345–345.
2.
Bunt, Gregory, et al.. (2024). Cannabis and Pregnancy. Current Psychiatry Reports. 26(11). 643–649.
3.
Wachtendorf, Luca J., Aiman Suleiman, Tim M. Tartler, et al.. (2023). Prevalence and association of non-medical cannabis use with post-procedural healthcare utilisation in patients undergoing surgery or interventional procedures: a retrospective cohort study. EClinicalMedicine. 57. 101831–101831. 8 indexed citations
4.
Smith, Stephen M., Staci A. Gruber, Scott E. Lukas, et al.. (2019). Denoising scanner effects from multimodal MRI data using linked independent component analysis. NeuroImage. 208. 116388–116388. 21 indexed citations
5.
DeVido, Jeffrey, Hilary S. Connery, & Kevin P. Hill. (2015). Sleep-disordered breathing in patients with opioid use disorders in long-term maintenance on buprenorphine-naloxone: A case series. Journal of Opioid Management. 11(4). 363–366. 11 indexed citations
6.
Fitzmaurice, Garrett M., Kathleen M. Carroll, Margaret L. Griffin, et al.. (2014). Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patients. Drug and Alcohol Dependence. 145. 121–126. 96 indexed citations
7.
Hill, Kevin P.. (2014). Medical Marijuana. Journal of Psychiatric Practice. 20(5). 389–391. 10 indexed citations
8.
Hill, Kevin P., Margaret L. Griffin, Hilary S. Connery, et al.. (2013). Association of cannabis use with opioid outcomes among opioid-dependent youth. Drug and Alcohol Dependence. 132(1-2). 342–345. 25 indexed citations
9.
Sofuoglu, Mehmet, James Poling, Kevin P. Hill, & Thomas R. Kosten. (2009). Atomoxetine Attenuates Dextroamphetamine Effects in Humans. The American Journal of Drug and Alcohol Abuse. 35(6). 412–416. 32 indexed citations
10.
Ana, Elizabeth J. Santa, Bruce J. Rounsaville, Tami Frankforter, et al.. (2009). d-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: A pilot investigation. Drug and Alcohol Dependence. 104(3). 220–227. 79 indexed citations
11.
Sofuoglu, Mehmet, et al.. (2008). Disulfiram enhances subjective effects of dextroamphetamine in humans. Pharmacology Biochemistry and Behavior. 90(3). 394–398. 12 indexed citations
12.
Hill, Kevin P. & Mehmet Sofuoglu. (2007). Biological Treatments for Amfetamine Dependence. CNS Drugs. 21(10). 851–869. 13 indexed citations
13.
Patkar, Ashwin A., et al.. (2006). Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patients. Psychopharmacology. 185(1). 123–132. 20 indexed citations
14.
Hill, Kevin P., et al.. (2004). Neuropsychiatric Illness in a Patient with Cobalamin G Disease, an Inherited Disorder of Vitamin B12 Metabolism. Harvard Review of Psychiatry. 12(2). 116–122. 7 indexed citations
15.
Patkar, Ashwin A., et al.. (2003). Relationship between Platelet Serotonin Uptake Sites and Measures of Impulsivity, Aggression, and Craving among African-American Cocaine Abusers. American Journal on Addictions. 12(5). 432–447. 7 indexed citations
16.
Patkar, Ashwin A., Kevin P. Hill, Robert C. Sterling, et al.. (2002). Serum prolactin and response to treatment among cocaine‐dependent individuals. Addiction Biology. 7(1). 45–53. 13 indexed citations
17.
Patkar, Ashwin A., et al.. (2000). ECT in the Presence of Brain Tumor and Increased Intracranial Pressure: Evaluation and Reduction of Risk. Journal of Ect. 16(2). 189–197. 30 indexed citations
18.
Hill, Kevin P., et al.. (1999). 3. ECT in the Presence of Brain Tumor and Increased Intracranial Pressure. Journal of Ect. 15(1). 106–106. 1 indexed citations
19.
Hill, Kevin P. & J. Stocks. (1962). ASSESSMENT OF VISION OF THE PRELITERATE CHILD. International Ophthalmology Clinics. 2(4). 817–826. 1 indexed citations
20.
Hill, Kevin P.. (1959). Experimental Aberrant Lipogenesis. A M A Archives of Ophthalmology. 61(3). 361–361. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026